Non-nucleoside inhibitors of the hepatitis C virus NS5B polymerase: discovery of benzimidazole 5-carboxylic amide derivatives with low-nanomolar potency

By Beaulieu P.L.   Bos M.   Bousquet Y.   DeRoy P.   Fazal G.   Gauthier J.   Gillard J.   Goulet S.   McKercher G.   Poupart M.-A.   Valois S.   Kukolj G.  

Bioorganic and Medicinal Chemistry Letters, Vol. 14, Iss. 4, 2004-02 ,pp. : 967-971

Elsevier

Access to resources Recommend Favorite

The metabolism and disposition of a potent inhibitor of hepatitis C virus NS3/4A protease

By Monteagudo E.   Fonsi M.   Chu X.   Bleasby K.   Evers R.   Pucci V.   Orsale M.V.   Cianetti S.   Ferrara M.   Harper S.   Laufer R.   Rowley M.   Summa V.  

Xenobiotica, Vol. 40, Iss. 12, 2010-12 ,pp. : 826-839

Informa Healthcare

Access to resources Recommend Favorite

Complex Formation of NS5B with NS3 and NS4A Proteins of Hepatitis C Virus

By Ishido S.   Fujita T.   Hotta H.  

Biochemical and Biophysical Research Communications, Vol. 244, Iss. 1, 1998-03 ,pp. : 35-40

Elsevier

Access to resources Recommend Favorite

Pre-clinical pharmacokinetics of UK-453,061, a novel non-nucleoside reverse transcriptase inhibitor (NNRTI), and use of in silico physiologically based prediction tools to predict the oral pharmacokinetics of UK-453,061 in man

By Allan G.   Davis J.   Dickins M.   Gardner I.   Jenkins T.   Jones H.   Webster R.   Westgate H.  

Xenobiotica, Vol. 38, Iss. 6, 2008-06 ,pp. : 620-640

Informa Healthcare

Access to resources Recommend Favorite

Cross-species absorption, metabolism, distribution and pharmacokinetics of BI 201335, a potent HCV genotype 1 NS3/4A protease inhibitor

By Duan Jianmin   Yong Chan-Loi   Garneau Michel   Amad Ma’an   Bolger Gordon   De Marte Josie   Montpetit Hélène   Otis Francois   Jutras Martin   Rhéaume Manon   White Peter W.   Llinàs-Brunet Montse   Bethell Richard C.   Cordingley Michael G.  

Xenobiotica, Vol. 42, Iss. 2, 2012-02 ,pp. : 164-172

Informa Healthcare

Access to resources Recommend Favorite